Johnson & Johnson received unfavorable news for the company on Tuesday, June 1, after the Supreme Court rejected its appeal for the cancellation of a court decision where it was ordered to pay $2.1 billion in penalty.
The case against Johnson & Johnson is about the allegations the asbestos in its talc powder caused cancer in women, specifically many have reportedly developed ovarian cancer. The talc powder products also include the baby powder that has been around since 1893.
The Supreme Court upheld the penalty order
The high court announced without any kind of argument that it will not hear the case thus the penalty will not be scrapped. According to the order, Justices Samuel Alito and Brett Kavanaugh recused or disqualified themselves from consideration of the case.
CNBC reported that Johnson & Johnson made a request for the Supreme Court to assess the penalty it received after the amount was sustained by the Missouri Supreme Court in 2020. Although the amount is high, this was already reduced from the initial $4 billion.
The company that develops medical devices, pharmaceuticals and consumer packaged goods stated it is facing over 21,000 lawsuits for the talc products. Thus, in May 2020, Johnson & Johnson shared that it has already halted the selling of talc-based baby powder in Canada and the United States.
The company cited lower demand for the said item due to the spread of misinformation concerning the talc powders’ safety. It added the legal cases have also negatively affected the brand.
J&J’s response to the decision
In any case, J&J’s appeal for the Supreme Court to review its penalty was turned down and the opponent’s lawyer’s argument played a role. Ken Starr, a former Whitewater prosecutor who is representing the women who sued Johnson & Johnson, wrote in his brief that the justices should not review the case because, for decades, the company has been aware that their talc powders are made with asbestos as one of its ingredients. The substance is said to be “highly carcinogenic with no known safe exposure level.”
Finally, Reuters reported that J&J said the decision left unresolved legal issues and maintained that its baby powder is safe. The company reiterated there are scientific evaluations that prove the “product is safe, does not contain asbestos, and does not cause cancer."


UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
China Trade Surplus Beats Forecasts in July as Exports Stay Strong
Oil Prices Slip as Hormuz Shipping Progress and Rising U.S. Crude Stocks Weigh on Market
Canada, US Hold Constructive Trade Talks as Tariff Negotiations Continue
BOJ Signals Faster Rate Hikes as Inflation Risks Raise September Move Odds
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Gold Price Hits Seven-Week High as Fed Rate Hike Bets Fade and Hormuz Deal Hopes Grow
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens
US Stock Futures Hold Steady as Iran Hormuz Deal and Earnings Shape Market Sentiment
Brazil Cuts Selic Rate to 14% as Inflation Eases but Risks Persist
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 



